![Insights from 2024 EHA Annual Meeting](http://media.vumedi.com/thumbs/channel_logo/2024/6/8d846ca9-a80f-4328-885e-a4302b90cd59.png.200x0_q85.png)
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: QuANTUM-First Trial - Newly Diagnosed FLT3-ITD+ AML Patients Receiving Chemo + Quizartinib vs. Placebo
By
Insights from 2024 EHA Annual Meeting
FEATURING
Esther Oliva
By
Insights from 2024 EHA Annual Meeting
FEATURING
Esther Oliva
Login to view comments.
Click here to Login